Impact of Two-Component Regulatory Systems PhoP-PhoQ and PmrA-PmrB on Colistin Pharmacodynamics in Pseudomonas aeruginosa

Por Ly, Neang S., Yang, Jenny, Bulitta, Jurgen B., Tsuji, Brian T.
Publicado em 2012

Quantifying Subpopulation Synergy for Antibiotic Combinations via Mechanism-Based Modeling and a Sequential Dosing Design

Por Landersdorfer, Cornelia B., Ly, Neang S., Xu, Hongmei, Tsuji, Brian T., Bulitta, Jürgen B.
Publicado em 2013

Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime against Pseudomonas aeruginosa

Por Bulitta, Jürgen B., Ly, Neang S., Yang, Jenny C., Forrest, Alan, Jusko, William J., Tsuji, Brian T.
Publicado em 2009

Pharmacodynamic Variability beyond That Explained by MICs

Por Soon, Rachel L., Ly, Neang S., Rao, Gauri, Wollenberg, Lance, Yang, Kuo, Tsuji, Brian, Forrest, Alan
Publicado em 2013

Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin

Por Bulman, Zackery P., Ly, Neang S., Lenhard, Justin R., Holden, Patricia N., Bulitta, Jürgen B., Tsuji, Brian T.
Publicado no Antimicrob Agents Chemother (2017)

Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery

Por Wittau, Mathias, Paschke, Stephan, Kurlbaum, Max, Scheele, Jan, Ly, Neang S., Hemper, Evelyn, Kornmann, Marko, Henne-Bruns, Doris, Bulitta, Jürgen B.
Publicado no Antimicrob Agents Chemother (2016)

Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes

Por Sharma, Rajnikant, Patel, Saloni, Abboud, Cely, Diep, John, Ly, Neang S., Pogue, Jason M., Kaye, Keith S., Li, Jian, Rao, Gauri G.
Publicado no Int J Antimicrob Agents (2016)

Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing

Por Lim, Lauren M., Ly, Neang, Anderson, Dana, Yang, Jenny C., Macander, Laurie, Jarkowski, Anthony, Forrest, Alan, Bulitta, Jurgen B., Tsuji, Brian T.
Publicado no Pharmacotherapy (2010)

Emergence of Polymyxin B Resistance Influences Pathogenicity in Pseudomonas aeruginosa Mutators

Por Bulman, Zackery P., Sutton, Mark D., Ly, Neang S., Bulitta, Jurgen B., Holden, Patricia N., Nation, Roger L., Li, Jian, Tsuji, Brian T.
Publicado no Antimicrob Agents Chemother (2015)

Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii

Por Rao, Gauri G., Ly, Neang S., Diep, John, Forrest, Alan, Bulitta, Jürgen B., Holden, Patricia N., Nation, Roger L., Li, Jian, Tsuji, Brian T.
Publicado no Int J Antimicrob Agents (2016)

Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa

Por Ly, Neang S., Bulman, Zackery P., Bulitta, Jürgen B., Baron, Christopher, Rao, Gauri G., Holden, Patricia N., Li, Jian, Sutton, Mark D., Tsuji, Brian T.
Publicado no Antimicrob Agents Chemother (2016)

Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model

Por Bulitta, Jürgen B., Yang, Jenny C., Yohonn, Liliana, Ly, Neang S., Brown, Silvia V., D'Hondt, Rebecca E., Jusko, William J., Forrest, Alan, Tsuji, Brian T.
Publicado em 2010

Two Mechanisms of Killing of Pseudomonas aeruginosa by Tobramycin Assessed at Multiple Inocula via Mechanism-Based Modeling

Por Bulitta, Jürgen B., Ly, Neang S., Landersdorfer, Cornelia B., Wanigaratne, Nicholin A., Velkov, Tony, Yadav, Rajbharan, Oliver, Antonio, Martin, Lisandra, Shin, Beom Soo, Forrest, Alan, Tsuji, Brian T.
Publicado no Antimicrob Agents Chemother (2015)

Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance

Por Ly, Neang S., Bulitta, Jürgen B., Rao, Gauri G., Landersdorfer, Cornelia B., Holden, Patricia N., Forrest, Alan, Bergen, Phillip J., Nation, Roger L., Li, Jian, Tsuji, Brian T.
Publicado no J Antimicrob Chemother (2015)

New Dosing Strategies for an Old Antibiotic: Pharmacodynamics of Front-Loaded Regimens of Colistin at Simulated Pharmacokinetics in Patients with Kidney or Liver Disease

Por Rao, Gauri G., Ly, Neang S., Haas, Curtis E., Garonzik, Samira, Forrest, Alan, Bulitta, Jurgen B., Kelchlin, Pamela A., Holden, Patricia N., Nation, Roger L., Li, Jian, Tsuji, Brian T.
Publicado em 2014

Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies

Por Rao, Gauri G., Ly, Neang S., Bulitta, Jürgen B., Soon, Rachel L., San Roman, Marie D., Holden, Patricia N., Landersdorfer, Cornelia B., Nation, Roger L., Li, Jian, Forrest, Alan, Tsuji, Brian T.
Publicado no J Antimicrob Chemother (2016)

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses

Por Chen, Bo, Vousden, Katherine A, Naiman, Brian, Turman, Sean, Sun, Hong, Wang, Shu, Vinall, Lisa M K, Kemp, Benjamin P, Kasturiangan, Srinath, Rees, D Gareth, Grant, Ethan, Hinrichs, Mary Jane, Eck, Steven, DiGiandomenico, Antonio, Jack Borrok, M, Ly, Neang, Xiong, Ximing, Gonzalez, Carlos, Morehouse, Christopher, Wang, Yue, Zhou, Yebin, Cann, Jennifer, Zhao, Weiguang, Koelkebeck, Holly, Okubo, Koshu, Mayadas, Tanya N, Howe, David, Griffiths, Janet, Kolbeck, Roland, Herbst, Ronald, Sims, Gary P
Publicado no Ann Rheum Dis (2019)